A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis

NCT04439526 · clinicaltrials.gov ↗

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Guselkumab

Sponsor

Janssen-Cilag S.p.A.